Ameritas Investment Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ameritas Investment Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.95M	Hold	15,235	–	–	0.06%	355
2025 Q4	$1.86M	Sell	15,235 -1,375	-8%	-$158K	0.06%	361
2025 Q3	$1.66M	Sell	16,610 -1,395	-8%	-$126K	0.05%	404
2025 Q2	$1.49M	Hold	18,005	–	–	0.05%	452
2025 Q1	$1.46M	Sell	18,005 -50	-0.3%	-$4.47K	0.05%	453
2024 Q4	$1.63M	Hold	18,055	–	–	0.05%	434
2024 Q3	$1.78M	Hold	18,055	–	–	0.06%	385
2024 Q2	$1.67M	Hold	18,055	–	–	0.06%	385
2024 Q1	$1.71M	Hold	18,055	–	–	0.06%	397
2023 Q4	$1.61M	Hold	18,055	–	–	0.06%	399
2023 Q3	$1.32M	Sell	18,055 -15	-0.1%	-$1.2K	0.05%	440
2023 Q2	$1.5M	Buy	18,070 +15	+0.1%	+$1.25K	0.06%	418
2023 Q1	$1.38M	Hold	18,055	–	–	0.05%	441
2022 Q4	$1.5M	Hold	18,055	–	–	0.06%	404
2022 Q3	$1.43M	Buy	18,055 +1,600	+10%	+$135K	0.06%	364
2022 Q2	$1.22M	Hold	16,455	–	–	0.05%	459
2022 Q1	$1.48M	Sell	16,455 -62	-0.4%	-$5.72K	0.05%	446
2021 Q4	$1.85M	Buy	16,517 +62	+0.4%	+$7.48K	0.06%	366
2021 Q3	$2.07M	Buy	16,455 +4,200	+34%	+$541K	0.08%	294
2021 Q2	$1.66M	Hold	12,255	–	–	0.06%	394
2021 Q1	$1.72M	Buy	12,255 +110	+0.9%	+$16.5K	0.07%	353
2020 Q4	$1.71M	Sell	12,145 -2,600	-18%	-$333K	0.08%	317
2020 Q3	$1.64M	Hold	14,745	–	–	0.07%	283
2020 Q2	$1.65M	Hold	14,745	–	–	0.08%	265
2020 Q1	$1.14M	Hold	14,745	–	–	0.06%	335
2019 Q4	$1.4M	Sell	14,745 -3,200	-18%	-$277K	0.06%	378
2019 Q3	$1.37M	Hold	17,945	–	–	0.06%	375
2019 Q2	$1.57M	Hold	17,945	–	–	0.07%	318
2019 Q1	$1.62M	Hold	17,945	–	–	0.08%	300
2018 Q4	$1.29M	Hold	17,945	–	–	0.07%	340
2018 Q3	$1.72M	Hold	17,945	–	–	0.08%	302
2018 Q2	$1.71M	Hold	17,945	–	–	0.08%	294
2018 Q1	$1.57M	Sell	17,945 -4,700	-21%	-$429K	0.08%	336
2017 Q4	$1.95M	Buy	22,645 +22,400	+9,143%	+$1.88M	0.09%	262
2017 Q3	$21K	Hold	245	–	–	﹤0.01%	2396
2017 Q2	$18K	Hold	245	–	–	﹤0.01%	2531
2017 Q1	$16K	Hold	245	–	–	﹤0.01%	2530
2016 Q4	$14K	Hold	245	–	–	﹤0.01%	1193
2016 Q3	$16K	Hold	245	–	–	﹤0.01%	1173
2016 Q2	$13K	Hold	245	–	–	﹤0.01%	1113
2016 Q1	$12K	Hold	245	–	–	﹤0.01%	1119
2015 Q4	$17K	Sell	245 -115	-32%	-$7.84K	﹤0.01%	1093
2015 Q3	$22K	Hold	360	–	–	﹤0.01%	1039
2015 Q2	$30K	Hold	360	–	–	﹤0.01%	1074
2015 Q1	$27K	Hold	360	–	–	﹤0.01%	1117
2014 Q4	$22K	Buy	+360	New	+$20.5K	﹤0.01%	1111

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameritas Investment Partners's XBI Position: Q1 2026 in Review

Ameritas Investment Partners held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 15,235 shares worth $1.95M. The position accounts for 0.06% of the portfolio, ranked #355.

Ameritas Investment Partners first reported a position in XBI in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.07M in Q3 2021. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Ameritas Investment Partners held 15,235 shares of State Street SPDR S&P Biotech ETF worth $1.95M as of Q1 2026.
Ameritas Investment Partners left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.06% of Ameritas Investment Partners's portfolio in Q1 2026, its #355 holding.
Ameritas Investment Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and has held it in 46 quarters since.
Ameritas Investment Partners's State Street SPDR S&P Biotech ETF position peaked at $2.07M in Q3 2021.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.